Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$2.83B |
| 2 |
International Flavors & Fragrances
IFF
|
+$2.17B |
| 3 |
Coca-Cola
KO
|
+$1.36B |
| 4 |
Merck
MRK
|
+$1.3B |
| 5 |
Broadcom
AVGO
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$14.4B |
| 2 |
Apple
AAPL
|
+$2.02B |
| 3 |
Walt Disney
DIS
|
+$1.85B |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$1.61B |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Financials | 13.93% |
| 3 | Healthcare | 13.1% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
aTyr Pharma
ATYR
$18.6M
| $1.31M | ﹤0.01% |
295,105
+44,958
| +18% | +$211K |
2015 Q2
23 quarters
|
|
3952
NanoViricides
NNVC
$35.2M
| $1.31M | ﹤0.01% |
278,057
+184,529
| +197% | +$835K |
2013 Q4
29 quarters
|
|
|
BSQR
3953
DELISTED
BSQUARE Corporation
BSQR
| $1.31M | ﹤0.01% |
382,463
-18,011
| -4% | -$68.5K |
2013 Q2
31 quarters
|
|
3954
Hallador Energy
HNRG
$572M
| $1.3M | ﹤0.01% |
694,330
-10,194
| -1% | -$17.4K |
2013 Q2
31 quarters
|
|
3955
ImmuCell
ICCC
$96M
| $1.3M | ﹤0.01% |
134,611
+41,230
| +44% | +$387K |
2014 Q3
26 quarters
|
|
|
PTE
3956
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $1.28M | ﹤0.01% |
46,227
+8,914
| +24% | +$276K |
2014 Q2
27 quarters
|
|
3957
IGC Pharma
IGC
$25.7M
| $1.28M | ﹤0.01% |
714,372
| – | – |
2019 Q2
7 quarters
|
|
|
BNBX
3958
DELISTED
BNB PLUS CORP
BNBX
| $1.28M | ﹤0.01% |
12
+1
| +9% | +$140K |
2015 Q1
24 quarters
|
|
3959
Nuwellis
NUWE
$1.74M
| – | – |
0
| – | – |
2020 Q1
4 quarters
|
|
|
WPG
3960
DELISTED
Washington Prime Group Inc.
WPG
| $1.26M | ﹤0.01% |
565,230
-1,333,242
| -70% | -$9.74M |
2014 Q2
27 quarters
|
|
3961
ClearOne Inc
CLRO
$8.21M
| $1.26M | ﹤0.01% |
23,308
| – | – |
2013 Q2
31 quarters
|
|
3962
Vanguard US Momentum Factor ETF
VFMO
$1.83B
| $1.26M | ﹤0.01% |
+10,163
| New | +$1.26M |
2021 Q1
0 quarters
|
|
3963
Rhinebeck Bancorp
RBKB
$202M
| $1.25M | ﹤0.01% |
121,020
| – | – |
2019 Q1
8 quarters
|
|
|
STSA
3964
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.25M | ﹤0.01% |
211,560
+22,752
| +12% | +$138K |
2019 Q3
6 quarters
|
|
3965
DELISTED
Applied UV, Inc. Common Stock
AUVI
| $1.25M | ﹤0.01% |
+998
| New | +$1.02M |
2021 Q1
0 quarters
|
|
3966
Astrotech Corp
ASTC
$10.6M
| $1.24M | ﹤0.01% |
18,907
+4,634
| +32% | +$328K |
2013 Q2
31 quarters
|
|
3967
DELISTED
Strata Skin Sciences
SSKN
| $1.24M | ﹤0.01% |
73,956
+10,063
| +16% | +$183K |
2013 Q2
31 quarters
|
|
3968
INVO Fertility Inc
IVF
$1.43M
| $1.22M | ﹤0.01% |
+10
| New | +$1.1M |
2021 Q1
0 quarters
|
|
3969
Air T
AIRT
$76.9M
| $1.22M | ﹤0.01% |
51,125
+2,200
| +4% | +$54.9K |
2014 Q1
28 quarters
|
|
3970
Beasley Broadcasting Group
BBGI
$18.2M
| $1.22M | ﹤0.01% |
21,471
+796
| +4% | +$38.8K |
2013 Q2
31 quarters
|
|
|
NMRD
3971
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $1.22M | ﹤0.01% |
158,981
+13,636
| +9% | +$90.3K |
2020 Q2
3 quarters
|
|
|
ID
3972
DELISTED
PARTS iD, Inc.
ID
| $1.21M | ﹤0.01% |
+154,571
| New | +$1.15M |
2021 Q1
0 quarters
|
|
3973
DELISTED
Alimera Sciences
ALIM
| $1.21M | ﹤0.01% |
125,958
+7,519
| +6% | +$61.6K |
2013 Q2
31 quarters
|
|
3974
Caesarstone
CSTE
$91.3M
| $1.2M | ﹤0.01% |
87,613
+9,633
| +12% | +$127K |
2015 Q4
21 quarters
|
|
3975
Aurinia Pharmaceuticals
AUPH
$2.19B
| $1.2M | ﹤0.01% |
92,426
-2,728
| -3% | -$39.6K |
2017 Q4
13 quarters
|
|
Similar funds
Vanguard Group's Q1 2021 Portfolio in Review
As of Q1 2021, Vanguard Group held 4,384 positions worth $3.7T, up 7.2% from $3.45T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Vanguard Group's Q1 2021 filing shows 178 new, 3,232 increased, 779 reduced and 51 closed positions. Its largest new stake was Ferguson: 8,485,384 shares worth $1.02B. The largest sale was Alibaba, an estimated $14.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2021 buy was Ferguson: 8,485,384 shares worth $1.02B.
- Vanguard Group added most to JPMorgan Chase in Q1 2021, an estimated $2.83B increase.
- Vanguard Group's biggest Q1 2021 reduction was Alibaba, cutting an estimated $14.4B.
- Vanguard Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $1.61B.
- Vanguard Group's ten largest holdings make up 19% of its $3.7T portfolio in Q1 2021.
- Vanguard Group opened 178 new positions and closed 51 in Q1 2021.
- Vanguard Group's portfolio value rose 7.2% quarter-over-quarter to $3.7T.
Based on Vanguard Group's 13F filing for Q1 2021, filed 14 May 2021.